Stories from Aachen.

FEV Group

Generative AI accelerates homologation: FEV simplifies country-specific type approval processes

Fraunhofer-Institut für Produktionstechnologie IPT

Transforming personalized medicine with AI-driven CAR-T manufacturing: Automated CAR-T cell production platform is ready for production

Grünenthal Group

Grünenthal announces acquisition of the rights to Cialis® from Lilly in Mexico, Brazil & Colombia

Aachen, Germany (ots) - - Grünenthal announces that it agreed to acquire the commercial rights to Cialis® from Eli Lilly and Company in Mexico, Brazil and Colombia, further strengthening Grünenthal's footprint in Latin America. - As part of the acquisition, Grünenthal will transfer the manufacturing of Cialis® to its production site in Chile. - Since 2017, ...

Grünenthal Group

Maren Thurow starts as new Head Global Communications at Grünenthal

Grünenthal Group

Apotex licenses exclusive Canadian rights to Qutenza® from Grünenthal

Aachen, Germany & Toronto, Canada, (ots) - Grünenthal, a global leader in pain management and related diseases, and Apotex Inc. ("Apotex"), the largest Canadian-based pharmaceutical company, announced today that they have entered into a strategic licensing agreement whereby Apotex will have the exclusive Canadian rights to Qutenza®, a topical, non-systemic, ...

FEV Group

FEV develops AI-supported driver monitoring system CogniSafe

Grünenthal Group

Grünenthal appoints Prof. Dr. Uli Brödl as Chief Scientific Officer

FEV Group

FEV and ProLogium develop high-performance vehicle battery

Grünenthal Group

Grünenthal and Averitas Pharma announce completion of recruitment for Phase III clinical trial with QUTENZA® in post-surgical neuropathic pain

Aachen, Germany/Morristown, N.J. (ots) - - The Phase III trial AV001 aims to evaluate QUTENZA® in post-surgical neuropathic pain (PSNP), a debilitating complication of surgery occurring after approximately 10 percent of all surgical procedures[1], thus affecting more than 3 million people with surgical procedures ...

Grünenthal Group

First participants enrolled in first-in-human Phase I clinical trial with nociceptin (NOP) receptor agonist

Aachen, Germany (ots) - Today, Grünenthal announced that the first participants have been enrolled in a first-in-human Phase I clinical trial for a nociceptin (NOP) receptor agonist. The trial will include 90 healthy volunteers and aims to demonstrate a favourable safety and tolerability profile and to confirm the ...

Fraunhofer-Institut für Produktionstechnologie IPT

2

Deep learning for real-time quality control: Aachen-based Fraunhofer Institutes improve defect detection in weld seams

Grünenthal Group

Grünenthal appoints Dr. Jan Adams as Chief Commercial Officer

Fraunhofer-Institut für Produktionstechnologie IPT

Life cycle assessment for energy-efficient and climate-friendly optics production

Grünenthal Group

Grünenthal acquires US-company Valinor Pharma and becomes global owner of Movantik®

Aachen, Germany (ots) - - Grünenthal acquires the pharmaceutical company Valinor Pharma, further strengthening Grünenthal’s footprint in the United States. - With the acquisition, Grünenthal becomes the global owner of Movantik® / Moventig® (naloxegol). - Since 2017, Grünenthal has invested more than €2 billion in successful M&A transactions, significantly ...

Grünenthal Group

2

Grünenthal announces significant investments in its Latin America production sites, further securing reliable medicine supply for patients

Fraunhofer-Institut für Produktionstechnologie IPT

5G Industry Campus Europe in Aachen expanded with Cloud RAN

Fraunhofer-Institut für Produktionstechnologie IPT

Hydrogen technologies at the Hannover Messe 2024: Fraunhofer IPT presents system designs for the production of bipolar plates, MEAs and pressure tanks

Fraunhofer-Institut für Produktionstechnologie IPT

Fraunhofer study report describes AI use cases and sustainable energy concepts

Fraunhofer-Institut für Produktionstechnologie IPT

Pooling expertise: Fraunhofer IPT and Harro Höfliger cooperate in the manufacturing of ATMP production systems

Fraunhofer-Institut für Produktionstechnologie IPT

Fraunhofer IPT conducts research into automated series production of optics with new glass press

Fraunhofer-Institut für Produktionstechnologie IPT

Fraunhofer study report on cybersecurity, digital twins and sustainability in production

Fraunhofer-Institut für Produktionstechnologie IPT

Joint expertise from industry and research: New regulations standardize optical coherence tomography

Fraunhofer-Institut für Produktionstechnologie IPT

Go-ahead for 6G in industry: EU funds technology development with more than 13 million euros

Fraunhofer-Institut für Produktionstechnologie IPT

Fraunhofer IPT manufactures super-lightweight frame for experiments in outer space